The BRAF mutation causes constitutive activation of the MAPKP, which leads to the high activating capacity of the MAPK pathway after a cascade of phosphorylation in the transcription of genes enhancing the differentiation, proliferation, inhibition of apoptosis, and survival of tumor cells [3]. The gene discussed is BRAF; the disease is neoplasm.